Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Harris & Harris Group to Host Conference Call on Third-Quarter 2011 Financial Results on November 11, 2011

Abstract:
The management of Harris & Harris Group, Inc., (NASDAQ: TINY), will hold a conference call to discuss the Company's financial results for its third quarter 2011, to update shareholders and analysts on our business and to answer questions, on Friday, November 11, 2011, at 10:00 a.m. Eastern Time.

Harris & Harris Group to Host Conference Call on Third-Quarter 2011 Financial Results on November 11, 2011

New York, NY | Posted on October 25th, 2011

What: Harris & Harris Group 3rd Quarter 2011 financial results conference call and webcast
When: Friday, November 11, 2011
Time: 10:00 a.m. (ET)
Live Call: (877) 303-9855, domestic
(408) 337-0154, international
Webcast: www.hhvc.com/events.cfm

Please access the site at least 15 minutes prior to the scheduled start time in order to download the required audio software (RealPlayer or Windows Media Player). A replay of the webcast and visual presentation will be accessible through the Company's website for 30 days following the live event. For those unable to listen to the call via the Internet, a replay of the call will be available until midnight Eastern Time on Friday, November 18, 2011 by dialing (706) 645-9291. The passcode for the replay is #20993168.

####

About Harris & Harris Group, Inc.
Harris & Harris Group is a publicly traded venture capital company that invests in nanotechnology and microsystems.

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2010, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the website www.HHVC.com has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.

For more information, please click here

Contacts:
Company Contact:

Douglas W. Jamison
Harris & Harris Group, Inc.
Chairman and Chief Executive Officer
(212) 582-0900

Investor Contact:

Harriet Fried/Jody Burfening
Lippert Heilshorn & Associates
(212) 838-3777

Copyright © Harris & Harris Group

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Research Reveals Exotic Quantum States in Double-Layer Graphene: Findings shed new light on the nature of electron interactions in quantum systems and establish a potential new platform for future quantum computers June 26th, 2019

Researchers unveil how soft materials react to deformation at molecular level June 24th, 2019

Nanometrics and Rudolph Announce Merger Agreement to Create a Premier Semiconductor Process Control Company June 24th, 2019

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp.ís Portfolio Company, TheStreet, Inc., Enters into Agreement to be Acquired by TheMaven, Inc. for $16.5 Million June 13th, 2019

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.76 as of March 31, 2019; an Increase of 4.5% From December 31, 2018 May 1st, 2019

180 Degree Capital Corp. to Report First Quarter 2019 Financial Results on Wednesday, May 1, 2019 and to Host a Conference Call on Thursday, May 2, 2019 April 26th, 2019

A Nanobiotechnology Startup from a small town in India attracts the Global Investors January 27th, 2019

Investments/IPO's/Splits

Nanometrics and Rudolph Announce Merger Agreement to Create a Premier Semiconductor Process Control Company June 24th, 2019

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

180 Degree Capital Corp.ís Portfolio Company, TheStreet, Inc., Enters into Agreement to be Acquired by TheMaven, Inc. for $16.5 Million June 13th, 2019

Arrowhead Pharmaceuticals to Present at Upcoming May 2019 Conferences May 3rd, 2019

Announcements

Research Reveals Exotic Quantum States in Double-Layer Graphene: Findings shed new light on the nature of electron interactions in quantum systems and establish a potential new platform for future quantum computers June 26th, 2019

Researchers unveil how soft materials react to deformation at molecular level June 24th, 2019

Nanometrics and Rudolph Announce Merger Agreement to Create a Premier Semiconductor Process Control Company June 24th, 2019

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 22nd, 2019

Financial Reports

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.76 as of March 31, 2019; an Increase of 4.5% From December 31, 2018 May 1st, 2019

180 Degree Capital Corp. to Report First Quarter 2019 Financial Results on Wednesday, May 1, 2019 and to Host a Conference Call on Thursday, May 2, 2019 April 26th, 2019

Nanometrics to Announce First Quarter Financial Results on April 30, 2019 April 10th, 2019

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 First Quarter Results January 25th, 2019

Events/Classes

Arrowhead Pharmaceuticals to Present at Upcoming June 2019 Conferences June 2nd, 2019

ACS selects Naomi Halas to represent Americas at ChinaNano: Rice U. pioneer wins 2019 ACS Nano Lectureship Award for the Americas May 29th, 2019

CEA-Leti Develops CMOS Process for High-Performance MicroLEDs That Could Overcome Display-Size Obstacles: New Concept Creates All-in-One RGB MicroLEDs, Eliminates Several Transfer Steps to Receiving Substrate & Boosts Performance May 16th, 2019

Arrowhead Pharmaceuticals to Present at Upcoming May 2019 Conferences May 3rd, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project